Adverse events associated with concurrent chemoradiation therapy in patients with head and neck cancer.
about
Functional outcomes after chemoradiotherapy of laryngeal and pharyngeal cancersPreservation of organ function in head and neck cancer.Evidence-based review of treatment options for patients with glottic cancer.Moving towards personalised therapy in head and neck squamous cell carcinoma through analysis of next generation sequencing data.Long-term functional and survival outcomes after induction chemotherapy and risk-based definitive therapy for locally advanced squamous cell carcinoma of the head and neckThe ENHANCES study--Enhancing Head and Neck Cancer patients' Experiences of Survivorship: study protocol for a randomized controlled trialSelecting a comparison group for 5-year oral and pharyngeal cancer survivors: two methodsEffect of low-level laser therapy on patient reported measures of oral mucositis and quality of life in head and neck cancer patients receiving chemoradiotherapy--a randomized controlled trial.Transoral robotic surgery for oropharyngeal cancer: long-term quality of life and functional outcomes.Head and neck cancer-specific survival based on socioeconomic status in Asians and Pacific Islanders.Functional swallowing outcomes following treatment for oropharyngeal carcinoma: a systematic review of the evidence comparing trans-oral surgery versus non-surgical management.G-8 indicates overall and quality-adjusted survival in older head and neck cancer patients treated with curative radiochemotherapy.Neighborhood deprivation and clinical outcomes among head and neck cancer patients.Gemcitabine-Based Chemoradiation in the Treatment of Locally Advanced Head and Neck Cancer: Systematic Review of Literature and Meta-Analysis.Treatment complications and survival in advanced laryngeal cancer: a population-based analysisTrends in chemoradiation use in elderly patients with head and neck cancer: Changing treatment patterns with cetuximabTreatment-related toxicities in older adults with head and neck cancer: A population-based analysisIdentifying early dehydration risk with home-based sensors during radiation treatment: a feasibility study on patients with head and neck cancer.A review of drugs in development for the personalized treatment of head and neck squamous cell carcinoma.Robotic surgery for oropharynx cancer: promise, challenges, and future directions.Impact of intensity-modulated and image-guided radiotherapy on elderly patients undergoing chemoradiation for locally advanced head and neck cancer.Incidence of hospitalization in patients with head and neck cancer treated with intensity-modulated radiation therapy.Extent of local invasion and safe resection in cT1-2 tonsil cancer.Personalizing Medicine in Head and Neck Squamous Cell Carcinoma: The Rationale for Combination TherapiesQuality of life outcomes of transoral robotic surgery with or without adjuvant therapy for oropharyngeal cancer.Association of Transoral Robotic Surgery With Short-term and Long-term Outcomes and Costs of Care in Oropharyngeal Cancer Surgery.Cohort study of oncologic emergencies in patients with head and neck cancer.Hyperthermia sensitization and proton beam triggered liposomal drug release for targeted tumor therapy.Neurocognitive function in head and neck cancer patients prior to treatment.Improving Quality of Life With Nabilone During Radiotherapy Treatments for Head and Neck Cancers: A Randomized Double-Blind Placebo-Controlled Trial.Survival outcomes in elderly patients with untreated upper aerodigestive tract cancer.Speech-language pathology care and short- and long-term outcomes of laryngeal cancer treatment in the elderly.Improving Adherence to Cancer Treatment by Addressing Quality of Life in Patients With Advanced Gastrointestinal Cancers.Burden, quality of life, and social support in caregivers of patients undergoing radiotherapy for head and neck cancer: A pilot studyRadiation dose to the tongue and velopharynx predicts acoustic-articulatory changes after chemo-IMRT treatment for advanced head and neck cancer.Implications of the oropharyngeal cancer epidemic.A clinic-supported group exercise program for head and neck cancer survivors: managing cancer and treatment side effects to improve quality of life.Two-year results of a prospective preventive swallowing rehabilitation trial in patients treated with chemoradiation for advanced head and neck cancer.A phase II study of intra-arterial cisplatin with concurrent radiation and erlotinib for locally advanced head and neck cancer.Functional organ preservation after chemoradiotherapy in elderly patients with loco-regionally advanced head and neck squamous cell carcinoma.
P2860
Q26866157-B4775F91-16C8-4D2A-83B6-CF8CFEE2D8A1Q30459136-BA7FB114-1E3C-4284-B3D7-E389EAE192BAQ31032091-A930320D-D140-4129-98AB-3B37043554DEQ31043365-55B446A6-C736-4E76-A4FE-F741179C1FE6Q33667302-A17D5DFF-2FB4-4F4C-984A-F0B029ED8747Q33740479-6518F238-3E6A-48F7-886D-75294CA50784Q34253669-03D59F78-5887-4B13-875D-9CA47577E987Q34504579-F7A1DCEA-5335-459B-97DB-3E2E19AD58D2Q34758380-8B8F5993-E506-48D8-8C8D-2082180FD346Q35051066-0A391424-2C5A-4B9C-ABB5-0C5FDFC605CDQ35751664-F12B8248-4B1D-491A-B755-9A2C457C051CQ35836618-CCE3BA26-1EE8-4481-AAE8-9D1CCF0EC2DBQ36024594-91E2BED9-60CE-4584-9B2A-2F4EEF246D0EQ36452263-ACD4C6C0-24E3-4FD9-A167-A3A9DE6E1B1CQ36766930-643A7941-505A-4EEA-9FF2-AC6F58F463B4Q37146157-302C1074-2B62-41CF-B80C-33885D4F7797Q37246284-1C3A62D2-A8F2-4855-9508-B472E7BE0F4FQ37438294-0865CEA9-E155-4A17-9A3A-8CDF9E80531AQ37669978-B34348A3-7F40-42D4-A2B5-693AEDBA52BBQ37981985-B59B281D-980A-4141-BE78-35536610D6AEQ38015697-11A887E4-9117-438E-9C26-F3BBA678D18AQ38225444-4B9F0F7D-B757-43B9-A3F8-4AD6980DD938Q38456703-DEE89D00-F32E-4C6D-8B31-32D746924DE0Q38586956-F12FE849-A88E-4F0D-9A75-F5A24E660F08Q38644215-9DF01A6C-8012-444F-91FE-649B4D9FE5BFQ38867075-29176F1C-C0B7-4598-8C20-861B7BCE01A0Q38873680-0A5830A8-75B9-4E48-9A40-79855E693CF5Q38992714-288FE1AC-DC3A-4241-9D0E-BC0C04090665Q39794213-2CF0BC8D-8E82-4EC6-B24D-42AC59EBE5AEQ40390118-1C26622C-D2A0-4788-A7F5-EFF6456CB028Q40628789-9D039AE5-2589-41BD-9E19-7009A9E53FF2Q40760262-3AD50FD9-5DDC-4C7D-B1E4-B9DD03E78112Q40938852-A9591355-D792-4E70-B0E2-0D14C4A6A4ECQ41048114-146ECE91-8931-464F-BB41-859BB1293401Q41501145-61058F64-DCA5-4C65-9E01-7763ECA3B43CQ43216545-4170646E-3971-4268-8AEF-7D52F2465E0CQ43804616-CEBD27A4-12CE-41BF-A0F8-CFCA0295BE65Q44004162-05B77D59-FAFC-4D03-BFCA-D5D92DDB3ECEQ44504104-CE8ECFF8-9BCF-4B3D-A516-8745C67FEFBCQ44792291-01BCAD64-9FBC-47C5-8631-925F81D97D4B
P2860
Adverse events associated with concurrent chemoradiation therapy in patients with head and neck cancer.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Adverse events associated with ...... nts with head and neck cancer.
@en
type
label
Adverse events associated with ...... nts with head and neck cancer.
@en
prefLabel
Adverse events associated with ...... nts with head and neck cancer.
@en
P2093
P50
P356
P1433
P1476
Adverse events associated with ...... nts with head and neck cancer.
@en
P2093
Anjali K Gupta
Daniel J Givens
Gerald H Clamon
Gerry F Funk
Lucy Hynds Karnell
P304
P356
10.1001/ARCHOTO.2009.174
P577
2009-12-01T00:00:00Z